REVIEW article
Front. Psychiatry
Sec. Psychological Therapy and Psychosomatics
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1648225
Effects of Cognitive Behavioral therapy on Cognition, Neuropsychiatric Symptoms, and Quality of Life in Alzheimer's Disease: A Meta-analysis
Provisionally accepted
- 1Jiangnan University Wuxi School of Medicine, Wuxi, China
- 2Wuxi Mental Health Centre, Wuxi, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder, often accompanied by cognitive decline and neuropsychiatric symptoms, which substantially impair patients' quality of life. Cognitive behavioral therapy (CBT) has shown effects in improving mood and quality of life in depression and anxiety, but systematic evidence of its application in AD is still limited. Objective: This study aims to systematically assess the efficacy of CBT interventions on global cognition, neuropsychiatric symptoms (including depression severity) and Quality of Life (QoL) in AD. Method: PubMed, Embase, Cochrane, and Web of Science databases were researched from the inception of each database to March 2025. The search strategy included MESH terms "Alzheimer Disease" and "Cognitive Behavioral Therapy", combined with the Boolean operator "AND". Randomized controlled trials involving CBT-adapted protocols were included. Data were pooled using random-effects models (Hedges' g with 95%CIs), with subgroup analyses by intervention duration. Meta-analyses were performed using Stata MP 18.0, with bias risk assessed by the Cochrane Risk of Bias tool RevMan 5.4. Result: A total of 15 randomized controlled trials (n=2,135 participants) were included. The meta-analysis showed that CBT significantly improved global cognition (MMSE: SMD=0.67, 95%CI=0.31 to 1.02, p<0.001), though heterogeneity was high (I²=86.9%). No significant effects were observed for neuropsychiatric symptoms, or QoL. Subgroup analyses revealed medium-term This is a provisional file, not the final typeset article interventions (8-16 weeks) reduced depressive symptoms and improved QoL, while long-term CBT (>16 weeks) enhanced cognition. Conclusions: CBT demonstrates significant benefits for global cognition in AD, with medium-term interventions effective for mood and QoL outcomes. These findings support CBT intervention as viable non-pharmacological strategies for AD management, though methodological limitations and considerable heterogeneity warrant cautious interpretation.
Keywords: Alzheimer's disease, cognitive behavioral therapy, cognition function, Neuropsychiatric symptoms, Systematic review, Meta-analysis, Quality of Life
Received: 16 Jun 2025; Accepted: 08 Sep 2025.
Copyright: © 2025 Gao, Yin, Sun, Li and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yue Wu, Wuxi Mental Health Centre, Wuxi, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.